Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells

  1. Monteagudo, S.
  2. Pérez-Martnez, F.C.
  3. Pérez-Carrin, M.D.
  4. Guerra, J.
  5. Merino, S.
  6. Snchez-Verd, M.P.
  7. Cñea, V.
Revue:
Nanomedicine

ISSN: 1743-5889,  1748-6963

Année de publication: 2012

Volumen: 7

Número: 4

Pages: 493-506

Type: Article

DOI: 10.2217/NNM.11.61 GOOGLE SCHOLAR
La source de données: Scopus